These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1847120)

  • 1. Anti-HCV screening of blood donors: the impact in Spain.
    Koff RS
    Gastroenterology; 1991 Mar; 100(3):839-41. PubMed ID: 1847120
    [No Abstract]   [Full Text] [Related]  

  • 2. Impacts of blood screening on the incidence of posttransfusion hepatitis C in Japan.
    Yoshizawa H; Watanabe J
    Curr Stud Hematol Blood Transfus; 1994; (61):182-94. PubMed ID: 7525155
    [No Abstract]   [Full Text] [Related]  

  • 3. Follow-up study of anti-hepatitis C virus antibodies in blood donors implicated in post-transfusion non-A, non-B hepatitis.
    Mazda T; Nakata K; Bannai M; Miyamura T; Chiba J; Ohba H; Kaminuma Y; Katayama T
    Transfus Med; 1993 Jun; 3(2):149-51. PubMed ID: 7690640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays.
    Aach RD; Stevens CE; Hollinger FB; Mosley JW; Peterson DA; Taylor PE; Johnson RG; Barbosa LH; Nemo GJ
    N Engl J Med; 1991 Nov; 325(19):1325-9. PubMed ID: 1656258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to hepatitis C virus in blood donors and polytransfused patients of Macau (southeast China).
    Martins IA; Ling RC; Fai EL; Chai H; do Rosário Vong MA; de Olim GA
    Vox Sang; 1993; 65(3):245-6. PubMed ID: 7504374
    [No Abstract]   [Full Text] [Related]  

  • 6. Low cost anti-HCV screening of blood donors.
    Neill AG; Conradie JD
    Lancet; 1992 Oct; 340(8827):1096. PubMed ID: 1357481
    [No Abstract]   [Full Text] [Related]  

  • 7. High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus.
    Esteban JI; López-Talavera JC; Genescà J; Madoz P; Viladomiu L; Muñiz E; Martin-Vega C; Rosell M; Allende H; Vidal X
    Ann Intern Med; 1991 Sep; 115(6):443-9. PubMed ID: 1651674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis.
    Esteban JI; González A; Hernández JM; Viladomiu L; Sánchez C; López-Talavera JC; Lucea D; Martin-Vega C; Vidal X; Esteban R
    N Engl J Med; 1990 Oct; 323(16):1107-12. PubMed ID: 2170839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serological diagnosis of anti-HCV antibodies. Tests for screening and confirmation: analytical study. Le groupe "Hépatites virales" de la Société Française de Transfusion Sanguine].
    Maniez-Montreuil M
    Rev Fr Transfus Hemobiol; 1992 Jul; 35(3):163-9. PubMed ID: 1329791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to hepatitis C virus in Croatian blood donors and polytransfused patients.
    Mihaljević I; Feldbauer J; Delajlija M; Grgicević D
    Vox Sang; 1992; 63(3):236. PubMed ID: 1333138
    [No Abstract]   [Full Text] [Related]  

  • 11. [Reduction of the proportion of anti-HCV-positive donations].
    Quiles FJ; Sanz A; Cabanillas A; Sáenz P; Sánchez GM; Díaz F
    Sangre (Barc); 1992 Apr; 37(2):153-4. PubMed ID: 1320294
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis C virus infection from blood and blood products.
    van der Poel CL
    FEMS Microbiol Rev; 1994 Jul; 14(3):241-6. PubMed ID: 7522022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The usefulness of determining ALT in the detection of anti-HVC-positive cases among blood donors].
    Suárez A; Linares A; San Román FS; Rodrigo L
    Med Clin (Barc); 1993 May; 101(1):38. PubMed ID: 8391100
    [No Abstract]   [Full Text] [Related]  

  • 14. [The diagnostic value of anti-HCV test in HCV infection].
    Liu FH; Tian GS; Fu XX
    Zhonghua Nei Ke Za Zhi; 1994 Apr; 33(4):229-31. PubMed ID: 7525166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of non-A, non-B hepatitis after screening blood donors for antibodies to hepatitis C virus and surrogate markers.
    Barrera JM; Bruguera M; Ercilla MG; Sánchez-Tapias JM; Gil MP; Costa J; Gelabert A; Rodés J; Castillo R
    Ann Intern Med; 1991 Oct; 115(8):596-600. PubMed ID: 1909848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme-linked immunosorbent assay for antibodies against the capsid protein of hepatitis C virus with a synthetic oligopeptide.
    Okamoto H; Munekata E; Tsuda F; Takahashi K; Yotsumoto S; Tanaka T; Tachibana K; Akahane Y; Sugai Y; Miyakawa Y
    Jpn J Exp Med; 1990 Aug; 60(4):223-33. PubMed ID: 1963454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative sensitivity of different solid-phase immunoassays for detecting HBsAg and anti-HCV in blood].
    León P; López JA; Domingo CJ; Echevarría JM
    Sangre (Barc); 1992 Oct; 37(5):407-10. PubMed ID: 1284096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A comparative analysis of blood donors with antibodies to the hepatitis C virus, positivity for the hepatitis B surface antigen and hypertransaminasemia in Asturias].
    Suárez A; Riestra S; Rodríguez M; Linares A; Otero L; Rodrigo L
    Med Clin (Barc); 1994 Jul; 103(6):209-13. PubMed ID: 7967864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of serologic testing for hepatitis C virus infection and risk of posttransfusion hepatitis C.
    Alter MJ
    Arch Pathol Lab Med; 1994 Apr; 118(4):342-5. PubMed ID: 7513149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive reactivity with anti-HCV ELISA in patients with autoimmune hepatitis--not confirmed with a neutralization test.
    Schvarcz R; von Sydow M; Weiland O
    Scand J Infect Dis; 1991; 23(1):127-8. PubMed ID: 1851321
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.